Zenas BioPharma, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Zenas BioPharma, Inc. (ZBIO) had Deferred Tax Assets, Operating Loss Carryforwards of $65.45 million as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-16
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $65.45M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $29.61M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.96M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $65.45M 10-K · filed 2026-03-16 |
| 2024-12-31 | $29.61M 10-K · filed 2026-03-16 |
| 2023-12-31 | $9.96M 10-K · filed 2025-03-11 |